Skip to main content

Table 4 Differentially expressed miRNAs (n=21) with an inconsistent direction between two studies

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

 miRNA name

Direction of expression

Studies with same direction (reference)

No. of tissue samples tested

Mean fold-change

Mean rank

hsa-miR-103

↑

AE, AP, AS, NB

167

2.72

87.00

 

↓

SZ

20

1.73

5.00

hsa-let-7d

↑

EJ, AP

32

6.82

11.50

 

↓

SA, AE

37

7.04

22.50

hsa-miR-26a

↑

AP

17

5.16

12.00

 

↓

AE, AS, SA

131

4.38

30.67

hsa-miR-146a

↑

AE, AS

102

2.08

12.00

 

↓

SA

29

3.03

9.00

hsa-miR-708

↑

AS, NA

254

3.15

43.50

 

↓

NB

48

9.26

7.00

hsa-miR-345

↑

AS

94

1.45

85.00

 

↓

EJ, NB

63

12.59

2.50

hsa-miR-376a

↑

EJ

15

7.79

17.00

 

↓

AE, AS

102

1.43

28.00

hsa-miR-494

↑

NA

160

4.23

41.00

 

↓

NB, AE

56

3.86

14.50

hsa-miR-423-5p

↑

SA

29

9.03

4.00

 

↓

YN, NB

113

2.77

30.00

hsa-miR-365

↑

SZ

20

1.75

2.00

 

↓

AE, AS

102

1.80

17.00

hsa-miR-130a

↑

NB

48

2.00

28.00

 

↓

AE, AS

102

1.62

29.50

hsa-miR-132

↑

AS

94

2.59

18.00

 

↓

SZ

20

3.05

1.00

hsa-miR-324-3p

↑

AS

94

1.95

39.00

 

↓

NB

48

2.16

50.00

hsa-miR-501-5p

↑

AS

94

1.59

64.00

 

↓

NB

48

2.02

52.00

hsa-miR-874

↑

AS

94

1.49

80.00

 

↓

NB

48

2.20

47.00

hsa-miR-518d-3p

↑

AS

94

1.30

103.00

 

↓

NA

160

15.35

9.00

hsa-miR-28-3p

↑

AS

94

1.28

104.00

 

↓

NB

48

4.49

23.00

hsa-miR-648

↑

NA

160

8.63

16.00

 

↓

NB

48

9.07

8.00

hsa-miR-575

↑

NA

160

7.52

22.00

 

↓

NB

48

4.38

24.00

hsa-miR-877

↑

NA

160

4.03

43.00

 

↓

NB

48

3.48

28.00

hsa-let-7g

↑

NB

48

2.44

21.00

 

↓

AE

8

1.06

45.00